BioSyntech logo

BioSyntech

16 employees · est. 1994

VS
Kerecis logo

Kerecis

Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.

517 employees · est. 2011 · Iceland

BioSyntech is the older company (1994 vs 2011); Kerecis is the larger of the two.

Side-by-Side Comparison

BioSyntech Kerecis
Founded
1994 older 2011
Headquarters
Not tracked yet Iceland
Employees
16 517 larger
Industry
Biotechnology, Health Care, Health and Wellness Health Care, Manufacturing, Medical Devices
Funding Stage
Series Unknown Debt Financing
Total Funding
Not tracked yet $210.77M
Funding Rounds
Not tracked yet 19
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Regenerative Medicine, Cellular Therapy, Wound Care, Burn Treatment, Surgical Procedures, Dental Applications, Omega-3, Fish-skin Technology, Tissue Regeneration, Startup, Investment, Healthcare Innovation, Biomedical Research
Website
biosyntech.com kerecis.com
BioSyntech logo

About BioSyntech

BioSyntech is a medical device company specialized in the development, manufacturing and commercialization of advanced biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. BioSyntech’s platform technology is a family of hydrogels called BST-Gel®, some of whic...

Kerecis logo

About Kerecis

Kerecis is a pioneering company in the cellular therapy and regenerative medicine market, using fish skin and fatty acids to revolutionize tissue healing. Founded in 2009 by Fertram Sigurjonsson, the company's patented technologies leverage fatty-acid rich products to enable tissue regeneration, min...

We will tell you when either one moves

BounceWatch watches BioSyntech and Kerecis for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioSyntech and Kerecis — by email.

Frequently Asked Questions

BioSyntech. Kerecis — Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative medicine market.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioSyntech has raised undisclosed funding while Kerecis has raised $210.77M.
BioSyntech and Kerecis operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioSyntech with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Kerecis on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy